Advertisement

The Latest

Arcion Therapeutics, a Baltimore-based clinical stage biotechnology company, received notice of allowance for a U.S. patent for its high-strength gel formulation of topical lidocaine, called ARC-2022, for pain associated with post-herpetic neuralgia and shingles, according to a company news release.

German researchers found a mutation in the TFAP2E gene might play a part in chemo-resistant colorectal cancer, according to findings published in the New England Journal of Medicine.

For SourceMedical, which provides information technology solutions to surgery centers, hospitals and rehabilitation chains, 2011 was a big year, with highlights including the launch of its new Revenue Cycle Solutions unit, hosting several webinars and earning its 10th consecutive year…

Advertisement